Join Our Mission

Collaborators & Investors

CereMark Pharma is building the leading molecular imaging company for degenerative neurological diseases that involve neuroproteinopathies (tau and beta-amyloid) by leveraging the considerable strengths of our internal team with that of like-minded medical, academic and biopharmaceutical collaborators. Our significant scientific, medical and regulatory expertise, combined with our openness to creative collaboration, make CereMark Pharma an ideal partner for organizations that share our enthusiasm for innovation and improved therapeutic and diagnostic options for patients who suffer the consequences of neurodegeneration and debilitating brain injury. 

If you are interested in an opportunity to advance the science of treating neurodegenerative diseases, contact us today to learn more.